Hepatitis C, Acute: Clinical Trials

3 trials for Hepatitis C, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Hepatitis C, Acute: new trials by email Literature Review of Hepatitis C, Acute trials Research Report on Hepatitis C, Acute

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in Egypt
BIOLINE HCV kits, ACCU-CHEK kits, ErKameter 3000 mercury manometer - Hepatitis C, Acute, Diabetes
CompletedCairo University719752018-10-012021-03-18
Cohort Study on People Who Inject Drugs in Senegal
Drug Addiction, HIV/AIDS
UnknownFrench National Agency for Research on AIDS and Viral Hepatitis2082016-08-242021-06-08
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P
Paritaprevir/ritonavir/ombitasvir, Dasabuvir, Ribavirin - Hepatitis C, Acute
Phase 3CompletedKirby Institute832016-06-012022-08-22

Narrower conditions

Hepatitis C (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Hepatitis B, Chronic (1)  ·  Hepatitis C, Chronic (1)  ·  Hypertension (1)  ·  Mental Disorders (1)  ·  Sexually Transmitted Diseases (1)  ·  Substance-Related Disorders (1)  ·  Tuberculosis (1)

Broader conditions

Blood-Borne Infections (3)  ·  Communicable Diseases (3)  ·  Digestive System Diseases (3)  ·  Flaviviridae Infections (3)  ·  Hepatitis (3)  ·  Hepatitis, Viral, Human (3)  ·  Infections (3)  ·  Liver Diseases (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)

Interventions

Blood Pressure Determination (1)  ·  Ribavirin (1)  ·  Viekira Pak (1)  ·  dasabuvir (1)  ·  glecaprevir and pibrentasvir (1)  ·  paritaprevir (1)

Sponsors

Cairo University (1)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Kirby Institute (1)

Countries

Australia (1)  ·  Egypt (1)  ·  New Zealand (1)  ·  Senegal (1)  ·  United Kingdom (1)

Top investigators

Gail Matthews, MBBS PhD (1)  ·  Moussa Seydi, M.D. (1)  ·  Pierre-Marie Girard, M.D., PhD (1)

Results publications

PMID 37771545